Tag Archive for: cancer vaccine

Mode of action of CY-101Cytovation ASA
Financing

Cytovation ASA bags additional US$6m to drive Phase II study

Cytovation ASA has baged US$6m to advance Phase II development of its bi-specific pore-forming peptide candidate CY-101 in patients with adrenocortical carcinoma.

Read more
EpiTcer platform. Neoantigen-loaded beads are phagocytised by DCs and present antigens to T-cells which in turn are activated. © NEOGAP Therapeutics
M&A

Neogap fully takes over TCER Oncology shares

Swedish personalised immunotherapy specialist Neogap Therapeutics AB has acquired the remaining shares of its subsidiary, TCER Oncology AB through two new shareholders.

Read more